CLICK ON COMPANY LOGO ABOVE FOR MORE INFO ON THE COMPANY
Keep all postings as they relate to Medical Marijuana, Inc., portfolio companies, brands or the stock.
Limit political posts unless you can relate to how it affects the company.
Give reference links for all posted information when available.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value.
Medical Marijuana, Inc. (MJNA ) is the first publicly held company vested in the medical marijuana and industrial hemp industries. The company is comprised of a diversified portfolio of hemp and cannabis based businesses. These businesses range from hydroponic stores, to pharmaceutical compounds derived legally from the hemp plant. The company has gone through many changes over the course of the past few years, some expected and some unexpected due to the nature of rapidly changing legal and political environments that surround marijuana and hemp in the United States. This ability to change has been one of the corner stones of MJNA's success in laying a much stronger foundation from which the industry can prosper.
At MJNA's inception, its focus was on providing educational seminars on medical marijuana and supporting the industry through technology, with its patent pending tax remittance card and compliance tracking software. Today the company has made significant advancements within a challenging industry. In the beginning, MJNA's market was made up of mom and pop dispensaries, collectives and trade shows, which were seen as the "hot gold rushes". Like many rapidly emerging industries, it seemed as if every ancillary business was a good investment opportunity. Today however, MJNA has honed its focus on several aspects of the medicinal and industrial markets and has laid a solid foundation for its growth worldwide.
The Medical Marijuana, Inc. (MJNA) team is made up of a diverse group of highly skilled professionals in their respected fields. Each individual who makes up the corporate structure of MJNA plays an integral part of the company's day to day operation and overall success. MJNA believes for a company to not merely succeed but thrive in any economic and political environment you must first have the right people on the team, make sure they are in the right position, and allow them to operate with integrity and an entrepreneurial spirit.
The MJNA executive team work with industry and world authorities on cannabinoid based science and technologies to source, evaluate, acquire and develop value added companies and products. Each of the entities that make Medical Marijuana Inc.'s structure has a clearly defined purpose as it relates to an individual market, consumer or partner need. By utilizing these different facets, MJNA is able to provide an unparalleled platform of businesses that are unique among industry competitors. The professionals at MJNA are dedicated to "keeping it simple". In an industry that has ever changing economic, political and scientific climate, its MJNA's team's ability to do just that that sets it apart.
Board of Directors
Dr. Stuart W. Titus, Ph.D.
Chief Executive Officer and President
Michelle L. Sides, Esq.
Chief Operations Officer
Robert L. Cunningham
Dr. Timothy R. Scott, Ph.D.
Michael D. Julian
Medical Marijuana, Inc.
12975 Brookprinter Place
Poway, CA 92064
Phone: (866) 273-8502
Stock Transfer Agent
First American Stock Transfer
4747 North 7th Street
Phoenix, AZ 85014
Toll Free: (877) 271-0548
Phone: (602) 485-1346
Facsimile: (602) 788-0423
Individual Investor Contacts
GH Investment Advisors
550 West C Street
San Diego, CA 92101
Toll Free: (877) 964-6463
Phone: (858) 264-6500
MJNA Security Details Share Structure
|Market Value1 ||$137,299,844 ||a/o Jun 08, 2015 |
|Shares Outstanding ||1,783,114,863 ||a/o Feb 26, 2015 |
|Float ||411,045,323 ||a/o Mar 31, 2013 |
|Authorized Shares ||5,000,000,000 ||a/o Sep 30, 2014 |
|Par Value ||0.001 |
|Shareholders of Record ||569 ||a/o Feb 24, 2015 |
Medical Marijuana and Industrial Hemp are both a species derived from the Cannabis. L. Sativa plant, but are completely different in their medical and industrial applications. Today, Cannabis has over 55,000 known uses from medicinal to industrial applications such as concrete, building materials, textiles, animal feed, fuel as well as a food which millions of people a day enjoy. What both of these species have in common is that they are grossly underutilized and misunderstood.
The History of Hemp as an industrial and medicinal product dates to the beginning of recorded history. It has been estimated that marijuana in the United States alone is a $110 billion market and the medical market makes up nearly $1.7 billion. Industrial hemp with its many uses such as fuel, food, textiles, building materials, and bioremediation is nearly impossible to quantify. Today the industry is fragmented and grossly underutilized, and under developed for a number of reasons that stretch date back hundreds of years. Mostly because of a stigma created from one species of the Cannabis plant that has a significantly higher amount of tetrahydrocannabinol (THC) and can be used as a recreational drug.
We invite you to read our Research and Development page as well as by clicking on the links below. If there is any relevant information that you feel we should share with our readers or with Medical Marijuana, Inc., please email us at email@example.com and we will be sure to make additional prudent information available to our shareholders, partners and the public.
U.S. States Pending Legislation
Legal Medical Marijuana States and DC
90 Physicians' View on Medical Marijuana
Votes and Polls, 2000-Present
News and Research
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.